The Reset Study (Geelong)

The study drug is a potential new treatment for Non-24 Sleep-Wake Rhythm Disorder (N24SWRD). This is a debilitating, chronic Circadian Rhythm Sleep-Wake Disorder (CRSWD) that occurs when individuals are unable to synchronize their master body clock (circadian clock/rhythm) to the 24-hour environmental light-dark cycle. This is commonly observed in people who are totally blind and not able to perceive light.

The study drug is an oral capsule, which is proposed as a new treatment to lessen the effects of N24SWRD by ’resetting’ the circadian system each day.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!